Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Goldsmith

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|December 21, 2020
Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled TrialMarcella Alsan, Fatima Cody Stanford, Abhijit Banerjee, et al.
Clinical Chemistry|August 16, 2005
Analysis of albumin-associated peptides and proteins from ovarian cancer patientsMark S Lowenthal, Arpita I Mehta, Kristina Frogale, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonistsAdrian Hall, Andy Billinton, Alan K Bristow, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2008
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacyAdrian Hall, Andy Billinton, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2008
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory painAdrian Hall, Susan H Brown, Christopher Budd, et al.
JAMA Network Open|July 14, 2021
Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical TrialCarlos Torres, Lucy Ogbu-Nwobodo, Marcella Alsan, et al.
Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|December 21, 2020
Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled TrialMarcella Alsan, Fatima Cody Stanford, Abhijit Banerjee, et al.
Clinical Chemistry|August 16, 2005
Analysis of albumin-associated peptides and proteins from ovarian cancer patientsMark S Lowenthal, Arpita I Mehta, Kristina Frogale, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonistsAdrian Hall, Andy Billinton, Alan K Bristow, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2008
Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacyAdrian Hall, Andy Billinton, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2008
Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory painAdrian Hall, Susan H Brown, Christopher Budd, et al.
JAMA Network Open|July 14, 2021
Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical TrialCarlos Torres, Lucy Ogbu-Nwobodo, Marcella Alsan, et al.
Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory painRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2006
Identification of novel pyrazole acid antagonists for the EP1 receptorStephen C McKeown, Adrian Hall, Gerard M P Giblin, et al.
Pageof 11